Oncobiologics (OTLK) Institutional Ownership $2.68 +0.27 (+11.20%) Closing price 04:00 PM EasternExtended Trading$2.74 +0.06 (+2.43%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oncobiologics (NASDAQ:OTLK)CurrentInstitutional OwnershipPercentage11.20%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$2.16MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$6.64M Get OTLK Insider Trade Alerts Want to know when executives and insiders are buying or selling Oncobiologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OTLK Institutional Buying and Selling by Quarter Oncobiologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025 Russell Investments Group Ltd.24,477$39K0.0%+865.2%0.073% 5/16/2025 Goldman Sachs Group Inc.103,524$126K0.0%+74.1%0.323% 5/16/2025 AQR Capital Management LLC84,671$103K0.0%+42.7%0.264% 2/17/2025 Tang Capital Management LLC182,502$345K0.0%-88.3%0.571% 2/14/2025 Jane Street Group LLC26,218$50K0.0%+133.9%0.082% 2/14/2025 Northern Trust Corp111,750$211K0.0%-6.0%0.349% 2/13/2025 Scotia Capital Inc.73,989$140K0.0%+124.4%0.231% 2/13/2025 Renaissance Technologies LLC130,374$246K0.0%N/A0.408% 2/13/2025 Russell Investments Group Ltd.17,168$32K0.0%+34,936.7%0.054% 2/10/2025 Commonwealth Equity Services LLC25,615$48K0.0%N/A0.080% Get the Latest News and Ratings for OTLK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncobiologics and its competitors with MarketBeat's FREE daily newsletter. 2/6/2025 Charles Schwab Investment Management Inc.36,048$68K0.0%-29.9%0.113% 2/4/2025 Bank of New York Mellon Corp29,764$56K0.0%+44.8%0.093% 1/30/2025 Rhumbline Advisers188,050$355K0.0%+1,329.6%0.588% 11/19/2024 Barclays PLC20,943$111K0.0%+677.4%0.089% 11/16/2024 Geode Capital Management LLC341,959$1.83M0.0%+49.2%1.445% 11/15/2024 Barclays PLC20,943$111K0.0%+677.4%0.089% 11/15/2024 XTX Topco Ltd37,328$199K0.0%N/A0.158% 11/15/2024 Sphera Funds Management LTD.413,545$2.21M0.4%-27.6%1.748% 11/15/2024 State Street Corp232,542$1.24M0.0%+10.0%0.983% 11/14/2024 Caligan Partners LP318,699$1.70M0.5%-36.3%1.347% 11/13/2024 Great Point Partners LLC1,293,028$6.91M2.0%-24.0%5.465% 11/12/2024 Charles Schwab Investment Management Inc.51,459$275K0.0%+55.1%0.217% 10/22/2024 Christensen King & Associates Investment Services Inc.10,276$55K0.0%N/A0.044% 8/15/2024 Susquehanna Fundamental Investments LLC41,020$303K0.0%N/A0.175% 8/15/2024 AQR Capital Management LLC10,164$75K0.0%N/A0.043% 8/14/2024 Squarepoint Ops LLC31,388$232K0.0%N/A0.134% 8/14/2024 Great Point Partners LLC1,701,510$12.56M2.4%+15.0%7.270% 7/16/2024 LVW Advisors LLC47,730$352K0.1%N/A0.204% 7/12/2024 Rosalind Advisors Inc.450,000$3.32M2.4%+44.3%1.922% 5/20/2024 Virtu Financial LLC18,213$217K0.0%-73.3%0.140% 5/14/2024 American International Group Inc.3,873$46K0.0%-95.0%0.030% 5/10/2024 Vanguard Group Inc.341,300$4.08M0.0%-94.8%2.623% 5/1/2024 BNP Paribas Financial Markets4,505$54K0.0%-94.8%0.035% 4/25/2024 Rosalind Advisors Inc.311,775$3.72M3.5%N/A2.396% 2/12/2024 Scotia Capital Inc.284,080$112K0.0%-16.1%0.109% 11/15/2023 Scotia Capital Inc.338,439$75K0.0%+420.9%0.130% 11/3/2023 Gables Capital Management Inc.154,500$34K0.0%+132.3%0.059% 10/24/2023 Bank of New York Mellon Corp434,567$96K0.0%-8.3%0.167% 9/21/2023 Barclays PLC30,963$54K0.0%-60.9%0.012% 8/7/2023 Lincoln National Corp320,300$557K0.0%+64.8%0.125% Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma8/4/2023 Main Street Financial Solutions LLC25,000$44K0.0%N/A0.010% 8/3/2023 Scotia Capital Inc.64,976$113K0.0%N/A0.025% 7/18/2023 Stratos Wealth Advisors LLC17,000$30K0.0%N/A0.007% 4/28/2023 SG Americas Securities LLC61,941$68K0.0%N/A0.024% 2/13/2023 GSA Capital Partners LLP277,785$300K0.0%+65.5%0.108% 2/10/2023 Vista Finance LLC277,615$300K0.4%-30.2%0.108% 2/8/2023 Lincoln National Corp194,300$210K0.0%+26.7%0.076% 2/7/2023 Metis Global Partners LLC48,289$52K0.0%+174.3%0.019% 1/17/2023 PPS&V Asset Management Consultants Inc.50,153$54K0.1%N/A0.022% 11/14/2022 Vista Finance LLC397,555$485K0.6%-61.0%0.176% 8/5/2022 Vista Finance LLC1,020,370$1.04M1.4%+3.7%0.452% 8/2/2022 Lincoln National Corp153,300$156K0.0%+48.4%0.068% 8/1/2022 Graypoint LLC37,500$38K0.0%-25.0%0.017% 7/26/2022 First Merchants Corp149,170$151K0.0%+45.1%0.066% 7/22/2022 LVW Advisors LLC1,733,633$1.77M0.4%-0.6%0.767% 7/18/2022 Gables Capital Management Inc.61,500$63K0.0%+32.3%0.027% 7/12/2022 Flower City Capital51,778$53K0.1%+158.9%0.023% 5/11/2022 GSA Capital Partners LLP256,200$456K0.1%+22.0%0.114% 5/2/2022 Gables Capital Management Inc.46,500$83K0.1%+1,228.6%0.021% 4/26/2022 Vista Finance LLC983,645$1.75M2.6%N/A0.439% 4/26/2022 First Merchants Corp102,770$182K0.0%+201.9%0.046% 4/19/2022 Graypoint LLC50,000$89K0.0%N/A0.022% 4/14/2022 Flower City Capital20,000$36K0.0%N/A0.009% 2/14/2022 GSA Capital Partners LLP210,042$286K0.0%N/A0.094% 2/10/2022 Alamar Capital Management LLC20,000$27K0.0%N/A0.009% 2/9/2022 Principal Financial Group Inc.36,686$50K0.0%+92.8%0.016% 2/8/2022 ProShare Advisors LLC19,461$26K0.0%+70.5%0.009% 2/8/2022 Northern Trust Corp817,545$1.11M0.0%-2.1%0.365% 2/7/2022 SG Americas Securities LLC25,235$34K0.0%-43.7%0.011% 2/4/2022 Envestnet Asset Management Inc.36,461$50K0.0%N/A0.016% 2/4/2022IndexIQ Advisors LLC187,692$255K0.0%-6.1%0.084% 2/2/2022 KWB Wealth27,284$37K0.0%N/A0.012% 2/2/2022 Oppenheimer & Co. Inc.22,100$30K0.0%+71.3%0.010% 1/27/2022 First Merchants Corp34,044$46K0.0%N/A0.015% 1/26/2022 Lincoln National Corp103,300$140K0.0%-59.2%0.046% 11/16/2021 Stelac Advisory Services LLC390,000$846K0.2%+39.3%0.222% 11/16/2021 Two Sigma Advisers LP309,900$672K0.0%-55.5%0.177% 11/16/2021 Two Sigma Investments LP271,534$589K0.0%-69.5%0.155% 11/15/2021 AXA S.A.145,013$315K0.0%-53.6%0.083% 11/12/2021 Renaissance Technologies LLC254,781$553K0.0%N/A0.145% 11/12/2021 Geode Capital Management LLC1,552,438$3.37M0.0%+2.4%0.885% 11/10/2021 Goldman Sachs Group Inc.151,110$328K0.0%+1,327.6%0.086% 11/10/2021IndexIQ Advisors LLC199,822$434K0.0%+11.1%0.114% 11/10/2021 Citigroup Inc.11,445$25K0.0%+174.5%0.007% 11/9/2021 Barclays PLC36,396$79K0.0%+113.8%0.021% 11/9/2021BlackRock Inc.5,838,612$12.67M0.0%+1.5%3.330% 11/9/2021 Principal Financial Group Inc.19,025$41K0.0%+35.9%0.011% 11/5/2021 Advisor Group Holdings Inc.30,246$66K0.0%-52.6%0.017% 11/2/2021 New York State Common Retirement Fund35,884$78K0.0%-52.2%0.020% 11/1/2021 SG Americas Securities LLC44,828$97K0.0%N/A0.026% Could This Be the End of Retirement Worries? (Ad)Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.Click here to see how to turn your savings into a monthly income machine.10/29/2021 Commonwealth Equity Services LLC21,522$46K0.0%N/A0.012% 10/28/2021Endurance Wealth Management Inc.15,000$33K0.0%N/A0.009% 10/22/2021 Strs Ohio27,000$58K0.0%+33.0%0.015% 10/18/2021 Coastal Investment Advisors Inc.16,000$35K0.0%+45.5%0.009% 8/17/2021 Walleye Capital LLC29,000$72K0.0%N/A0.017% 8/16/2021 Squarepoint Ops LLC11,200$28K0.0%-37.4%0.006% 8/16/2021 AQR Capital Management LLC35,995$90K0.0%N/A0.021% 8/16/2021 Amalgamated Bank16,537$41K0.0%N/A0.010% 8/16/2021 California State Teachers Retirement System121,237$302K0.0%N/A0.070% 8/16/2021 Charles Schwab Investment Management Inc.220,066$548K0.0%+539.1%0.127% (Data available from 1/1/2016 forward) OTLK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OTLK shares? During the previous two years, 29 institutional investors and hedge funds held shares of Oncobiologics. The most heavily invested institutionals were Great Point Partners LLC ($6.91M), Vanguard Group Inc. ($4.08M), Rosalind Advisors Inc. ($3.32M), Sphera Funds Management LTD. ($2.21M), Geode Capital Management LLC ($1.83M), Caligan Partners LP ($1.70M), and State Street Corp ($1.24M).Learn more on Oncobiologics' institutional investors. What percentage of Oncobiologics' stock is owned by institutional investors? 11.20% of Oncobiologics' stock is owned by institutional investors. Learn more on OTLK's institutional investor holdings. Which institutional investors have been buying Oncobiologics' stock? Of the 21 institutional investors that purchased Oncobiologics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rosalind Advisors Inc. ($450K), Scotia Capital Inc. ($314.49K), Great Point Partners LLC ($221.51K), Rhumbline Advisers ($174.90K), Renaissance Technologies LLC ($130.37K), Geode Capital Management LLC ($112.81K), and Gables Capital Management Inc. ($88K). How much institutional buying is happening at Oncobiologics? Institutional investors have bought a total of 741,003 shares in the last 24 months. This purchase volume represents approximately $2.16M in transactions. Which of Oncobiologics' major shareholders have been selling company stock? The following institutional investors have sold Oncobiologics stock in the last 24 months: Tang Capital Management LLC ($1.38M), Great Point Partners LLC ($408.48K), Caligan Partners LP ($181.30K), Sphera Funds Management LTD. ($157.88K), Charles Schwab Investment Management Inc. ($15.41K), and Northern Trust Corp ($7.12K). How much institutional selling is happening at Oncobiologics? Institutional investors have sold a total of 2,147,254 shares in the last 24 months. This volume of shares sold represents approximately $6.64M in transactions. Related Companies DBV Technologies Institutional Ownership Annexon Institutional Ownership Monte Rosa Therapeutics Institutional Ownership 4D Molecular Therapeutics Institutional Ownership Zhengye Biotechnology Institutional Ownership Prima BioMed Institutional Ownership scPharmaceuticals Institutional Ownership Galectin Therapeutics Institutional Ownership Puma Biotechnology Institutional Ownership Aardvark Therapeutics Institutional Ownership This page (NASDAQ:OTLK) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncobiologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncobiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access